News

Dr. Nikki Tavasoli Joins Ocean Tomo to Enhance Economic Insights

Dr. Nikki Tavasoli Joins Ocean Tomo to Enhance Economic Insights

Dr. Nikki Tavasoli Joins Ocean Tomo

Ocean Tomo, a key player in the consulting landscape, warmly welcomes Dr. Nikki Tavasoli, a former economist from the FDA. This strategic addition brings substantial expertise in economic modeling, specifically focusing on antitrust and intellectual property damages that bolster outcomes in the pharmaceutical, life sciences, and healthcare sectors.

Enhancing Economic Modeling

As a prominent figure in economic analysis, Dr. Tavasoli specializes in utilizing econometric modeling, advanced machine learning, and causal inference methodologies in high-stakes regulatory environments. Her impactful insights are designed to support clients in making informed decisions amidst complex disputes.

Experience at the FDA

During her time at the U.S. Food and Drug Administration, Dr. Tavasoli led extensive investigations into critical issues such as drug pricing, market competition, and healthcare policy dynamics. Her experience is marked by the development of innovative predictive frameworks that assess market behaviors and regulatory impacts. The analysis of generic drug life cycles and the formulation of pricing models for opioids contributed significantly to informing crucial federal policies.

Research Focus and Impact

Dr. Tavasoli's research intermingles behavioral economics with health policy, emphasizing advanced data science principles. Her peer-reviewed studies cover various topics, including medical expenditure forecasting and pollution mitigation economics. She excels in translating intricate quantitative analyses into clear, actionable insights tailored for legal, regulatory, and business professionals. Using tools such as Python, R, SQL, and Stata, she brings a wealth of knowledge and skill to the table.

Strategic Contributions to Ocean Tomo

James E. Malackowski, Chief Intellectual Property Officer at J.S. Held and Co-founder of Ocean Tomo stated, "Bringing a former FDA economist like Dr. Tavasoli on board significantly enhances our capacity to support life sciences clients with depth and rigor. The insight she provides into regulatory frameworks and market dynamics is invaluable for our expert testimony and IP strategy formulation, particularly in drug development and litigation matters."

Expertise Beyond Traditional IP Matters

Stephanie Giammarco, who spearheads Disputes, Valuations, and Financial Advisory services for J.S. Held, indicated that Dr. Tavasoli's skills extend beyond conventional intellectual property issues. Her proficiency supports varied engagements, including those involving regulatory disputes and commercial litigation. Furthermore, evaluating the economic impacts of regulatory changes offers clients a nuanced understanding of how policy shifts can sway market dynamics and competitively influence pricing and damages assessments.

Ocean Tomo's robust understanding of intellectual property value is cultivated through its involvement in matters relating to intangible assets—covering strategic planning, investments, disputes, and transactions. Each litigation outcome refines valuation methodologies, while advisory work is heavily informed by practical insights drawn from marketplace realities. This feedback loop enriches the team's ability to deliver precise, actionable advice across diverse situations involving intangible assets.

About J.S. Held

J.S. Held operates as a global consulting entity, merging technical, scientific, financial, and strategic expertise to facilitate clients in maximizing value while minimizing risks. The firm's professionals are strategically positioned as trusted advisors for organizations navigating high-stakes matters that require immediate attention, unwavering integrity, verified experience, and a comprehensive grasp of both tangible and intangible assets.

With over 1,500 experts serving clients across six continents, J.S. Held’s footprint includes 84% of the Global 200 Law Firms, 75% of the Forbes Top 20 Insurance Companies, and 71% of Fortune 100 Companies, among others.

J.S. Held is not a certified public accounting entity and does not engage in audit or attest services. Additionally, J.S. Held operates as a consulting firm and does not provide legal advice.

Media Inquiries

For media inquiries, please reach out to Kristi L. Stathis at J.S. Held, phone: +1 786 833 4864.

Frequently Asked Questions

What is Dr. Nikki Tavasoli's role at Ocean Tomo?

Dr. Nikki Tavasoli joins Ocean Tomo as an economist specializing in advanced economic modeling for antitrust and IP damages.

What previous experience does Dr. Tavasoli have?

She previously worked at the FDA, focusing on drug pricing, market competition, and policy impacts using data-driven insights.

What is Ocean Tomo's focus?

Ocean Tomo specializes in intellectual property and economic consulting, providing expertise across various sectors including life sciences and healthcare.

How does Dr. Tavasoli contribute to Ocean Tomo's services?

Her expertise enhances Ocean Tomo's capabilities in providing nuanced insights for complex legal and regulatory challenges related to IP strategy and valuation.

What kind of research does Dr. Tavasoli conduct?

Her research intersects behavioral economics, health policy, and advanced data science, contributing valuable insights for stakeholders across the industry.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 19

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
LBT Unveils Game-Changing Cyclotron for Medical Advances

Updated Category News Views 10

Unveiling the LB-30 Cyclotron at EANM 2026 Life in nuclear medicine never stands still, and once again, Longevous Beamtech (LBT) is stirring the pot with its brand-new LB-30 series medical cyclotron. They rolled out this high-powered beast at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM 2026) in Vienna. Leaning into the 30 MeV energy...

Continue Reading
Moore Law Urges Millrose Investors: Join the Action

Updated Category News Views 9

Is Millrose Playing a Risky Game? When I caught wind of this latest debacle with Millrose Properties, Inc. (NYSE: MRP), my gut reaction was a mix of curiosity and skepticism. Hunterbrook Media's report just blasted across the headlines, digging up some dirt on Millrose's recent financial maneuvers. Apparently, these cats have been busy buying homes to the tune of $200...

Continue Reading
Tenet® Beef: Revolutionizing Tenderness in America's Steaks

Updated Category News Views 5

Cracking the Code: A Genetic Leap in Beef Tenderness Well, buckle up, folks, because Callipyge Genetics is shaking things up in the beef aisle with their genomic breakthrough, Tenet®. It's about time we see some real innovation in an industry that's, let's face it, been slow to evolve. This isn't just a flash in the pan—a bit of DNA parsing has uncovered how to...

Continue Reading
OppFi Readies Q3 Earnings; Investors Eye Financials

Updated Category News Views 6

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Continue Reading
New Chapter Recovery Garners Key Accreditations

Updated Category News Views 9

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Continue Reading
Tumor Ablation Market: Charting a Billion-Dollar Surge

Updated Category News Views 14

Cancer's Unforgiving Climb: Opportunity Amidst Challenge Looking at the current state of the global tumor ablation market, one thing's clear—it's on a sort of upward swing you'd expect trains to make, riding the rails of rising cancer rates and technological advancements. At least that's what the folks at Wissen Research are banking on, projecting a leap to $1.8 billion...

Continue Reading
Netcapital Faces Securities Fraud Claims: Key Investor Notes

Updated Category News Views 5

Netcapital Under Fire: The Suit Unfolds You ever see a stock go through such highs and lows that you wish you had popcorn on standby? Well, that's where Netcapital Inc. (NASDAQ: NCPL) is sitting right now, in the midst of a class action lawsuit that's got investors' heads spinning. The accusations are serious: false and misleading statements about revenues that seem to...

Continue Reading
Kenneth Smith Takes Helm for Trends Int’l Expansion

Updated Category News Views 11

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Continue Reading
Dickinson Brands Celebrates Witch Hazel Legacy with Event

Updated Category News Views 18

Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...

Continue Reading

Top 5 Most Recently Viewed Articles

Outset Medical Set to Reveal Q1 Financials on May 7, 2025

Updated Category News Views 230

Outset Medical to Announce Q1 Financial Results Soon Outset Medical, Inc. (NASDAQ: OM), a trailblazer in medical technology based in San Jose, has its sights set on May 7, 2025, to announce its first quarter financial results. As a company recognized for its innovative approach to dialysis technology, Outset continually works to simplify and enhance the healthcare...

Continue Reading
Market Recap: Italian Stocks Shift Amid Sector Performance

Updated Category News Views 240

Italian Stock Market Overview The Italian stock market experienced a decline after the close on Thursday, reflecting a mix of sector performances that influenced overall investor sentiment. The trading landscape was characterized by various shifts among different stocks, revealing the ongoing dynamics within the marketplace. Key Index Performance As trading drew to a...

Continue Reading
The Digital Maps Market Surges with 18.50% Annual Growth Rate

Updated Category News Views 184

Overview of the Digital Maps Market Growth The Digital Maps Market is experiencing significant expansion, driven by an escalating need for real-time navigation, urban mobility enhancement, and the integration of AI-powered location intelligence. Key industry players are witnessing accelerated adoption across various sectors, including automotive, logistics, and smart city...

Continue Reading
Market Reactions Post-Nvidia Earnings: What Lies Ahead?

Updated Category News Views 181

A Look Into Market Reactions to Nvidia's Earnings In the world of finance, earnings reports serve as pivotal moments that can sway market sentiments significantly. Recently, Nvidia (NASDAQ: NVDA) released its much-anticipated earnings report, generating considerable buzz among investors. However, the results sparked a mixed reaction in the markets, leading many to...

Continue Reading
TVS Motor Company Expands Global Footprint with Morocco Launch

Updated Category News Views 267

TVS Motor Company Expands into Morocco Market TVS Motor Company (TVSM), a renowned global leader in the automotive industry, specifically in the two and three-wheeler sector, is excited to announce its strategic entry into the Moroccan market. This initiative is made possible through a collaboration with its dedicated distribution partner, Hindi Motors. As part of this...

Continue Reading